Company Profile
Solventum Corporation is a USA-based healthcare solutions provider, headquartered in Eagan, Minnesota, USA. Spun off from 3M Company (NYSE: MMM) in April 2024, the company operates as an independent publicly listed entity on NYSE (SOLV), led by Chief Executive Officer Bryan Hanson. With approximately 22,000 employees, Solventum serves hospitals, dental practices, and health systems globally.
Core Products ＆ Technologies
MedSurg
• Advanced Wound Care: Negative pressure wound therapy (NPWT), advanced wound dressings, skin care, and synthetic tissue matrices
• Infection Prevention ＆ Surgical Solutions: I.V. site management, sterilization assurance, temperature management, surgical supplies, medical tapes, stethoscopes, and electrodes
• Key Brands: PREVENA™ incision management, V.A.C.® therapy, and Tegaderm™ antimicrobial dressings
Dental Solutions
• Restorative Products: Tooth-colored composites, restorative cements, and bonding agents
• Orthodontic Solutions: Brackets and aligners for preventive and corrective dental care
• Key Brand: Filtek™ digital restorative workflow
Health Information Systems
• Clinical Documentation: Computer-assisted physician documentation and speech recognition platforms
• Revenue Cycle Automation: Direct-to-bill coding automation and classification methodologies
• Data Visualization: Analytics platforms designed to eliminate revenue cycle waste and support value-based care
• Key Brand: 360 Encompass™ software suite
Market Position ＆ Certifications
Solventum holds a leading global position in advanced wound care, dental materials, and health IT, competing with Smith ＆ Nephew, Coloplast, Becton Dickinson, and Dentsply Sirona. Key strengths include:
• 70+ years of healthcare innovation heritage inherited from 3M
• First-to-market legacy: Pioneer of negative pressure wound therapy and antimicrobial transparent film dressings
• Regulatory compliance: FDA cleared, CE marked, and ISO certified across global manufacturing facilities
• Clinical validation: V.A.C.® therapy supported by 2,000+ peer-reviewed published studies
• Global reach: Direct sales and distributor network serving healthcare professionals worldwide
Corporate Timeline
2024 — Spun off from 3M and began trading independently on NYSE (SOLV) on April 1
2025 — Divested the Purification and Filtration segment to focus on core healthcare solutions
2025 — Acquired Acera, expanding advanced wound care portfolio into regenerative tissue matrices
2026 — Opened Eagan Hub R＆D center of excellence and Brookings manufacturing plant expansion
2026 — Maintains operations through three segments: MedSurg, Dental Solutions, and Health Information Systems
Target Markets ＆ Applications
• Hospital ＆ Acute Care: Advanced wound care, surgical supplies, and infection prevention for operating rooms and inpatient units
• Dental Practices ＆ Orthodontics: Restorative composites, cements, and aligners for preventive and corrective procedures
• Health Systems ＆ Revenue Cycle: Clinical documentation, coding automation, and data analytics for hospitals and payers
• Out-of-Hospital Care: NPWT and wound dressings for ambulatory surgical centers, skilled nursing, and home care settings
Contact Information
Global Headquarters
Address: 1750 Yankee Doodle Road, Eagan, MN 55121, USA
Telephone: 1-800-228-3957
Website: www.solventum.com
Investor Relations
Solventum Corporation
Stock: NYSE: SOLV
Email: investors@solventum.com
Website: investors.solventum.com
Legacy Corporate Office
3M Center, Building 275-6W
Address: 2510 Conway Avenue East, Maplewood, MN 55144, USA
